Dissemination & Implementation Core
传播
基本信息
- 批准号:10469414
- 负责人:
- 金额:$ 32.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptionAwarenessCaringCase StudyChargeClinicalCommunity PracticeConsensusDataDissemination and ImplementationDoctor of PhilosophyEducationEducational workshopEthicsEvidence based treatmentFosteringFundingGoalsGrantInternationalKnowledgeMeasurementMental HealthMentorsMentorshipMethodsNational Institute of Drug AbusePaperPersonsPopulationPopulation HeterogeneityProcessPublic HealthPublicationsPublishingResearchResearch MethodologyResearch PersonnelResearch SupportResourcesScienceScientific Advances and AccomplishmentsServicesSpecific qualifier valueStudentsSubstance Use DisorderTechnologyTherapeutic Human ExperimentationTherapeutic UsesTrainingTraining ProgramsTraining SupportTraining and EducationTranslationsUnderrepresented MinorityUnderrepresented PopulationsWorkadaptive interventionbasecare systemsclinical implementationcommunity collegecostdigitaldigital healthdigital treatmentdissemination strategydual diagnosiseffective therapyimplementation barriersimplementation researchimplementation scienceimprovedknowledge basenext generationphysical conditioningpre-doctoralscale upskillssocial mediasubstance use treatmentsymposiumtherapy developmentweb site
项目摘要
DISSEMINATION AND IMPLEMENTATION CORE PROJECT SUMMARY
Digital therapeutics have demonstrated potential to meet service needs and accelerate translation of science to
practice. The charge of the Dissemination and Implementation (D&I) Core is to provide education, training,
resources, and scientific guidance to advance implementation science and practice for digital therapeutics for
SUDs and CODs. Over the past nine years, the D&I Core has supported activities to promote awareness about
the science of digital therapeutics for SUDs and CODs through traditional and digital dissemination channels
and developed resources to support application of implementation science in digital therapeutic research. Core
affiliates have advanced a conceptual understanding of how implementation science can be applied to digital
therapeutic research and contributed to the knowledge base of facilitators and barriers to implementation of
digital therapeutics for SUDs across a range of populations and settings. In this renewal, the Core will
continue to promote awareness about the science of digital therapeutics (Aim 1) through education,
mentorship, and expansion of the CTBH digital platform features to promote cumulative knowledge about
clinical evidence for digital therapeutics for SUDs and CODs. As new activities, D&I will work with the Center’s
Stakeholder Advisory Board to identify the stakeholder information priorities to inform targeted dissemination
strategies and will add a feature to the CTBH website to advance cumulative knowledge about digital
therapeutic implementation research. The D&I Core will support adoption and implementation of digital
therapeutics (Aim 2) through expanding and refining resources to promote application of implementation
science in digital therapeutic research, including implementation case studies and a common implementation
measurement framework. New in this renewal, the Core will conduct activities to systematically specify
strategies that accelerate implementation of digital therapeutics and offer tutorials to foster actionable skills for
digital therapeutic implementation research. To support new Center priorities, the Core will also engage
affiliates with active later stage digital health projects to include common clinical and implementation metrics to
inform methods for scaling of digital therapeutics, contribute training and methods for use of digital therapeutic
usage data and other digital assessment in studies to elucidate implementation mechanisms of action and
inform adaptive interventions, promote scientific understanding of determinants and strategies associated with
implementation of transdiagnostic digital treatments, provide training and resources in digital health ethics with
regard to access equity and cultural relevance of digital therapeutics, and support training and methods to
increase representation of underrepresented populations in digital therapeutic research. These efforts will
advance the state of implementation science and practice for digital therapeutics for SUDs and CODs.
传播和实施核心项目摘要
数字疗法已显示出满足服务需求并加速科学转化的潜力
传播和实施(D&I)核心的职责是提供教育、培训、
资源和科学指导,以推进数字疗法的实施科学和实践
SUD 和 COD 在过去的九年里,D&I 核心支持了旨在提高人们认识的活动。
通过传统和数字传播渠道进行 SUD 和 COD 的数字治疗科学
并开发资源以支持数字治疗核心研究中的实施科学应用。
附属机构对如何将实施科学应用于数字化有了概念性的理解
治疗研究,并为促进者和实施障碍的知识库做出了贡献
在这次更新中,核心将针对不同人群和环境的 SUD 提供数字疗法。
继续通过教育提高人们对数字疗法科学的认识(目标 1),
指导和扩展 CTBH 数字平台功能,以促进累积知识
SUD 和 COD 数字疗法的临床证据作为新活动,D&I 将与该中心合作。
利益相关者咨询委员会确定利益相关者信息优先事项,为有针对性的传播提供信息
战略,并将在 CTBH 网站上添加一项功能,以推进有关数字化的累积知识
D&I 核心将支持数字化的采用和实施。
疗法(目标2)通过扩大和细化资源来促进应用实施
数字治疗研究中的科学,包括实施案例研究和通用实施
此次更新的新内容是,核心将开展活动来系统地指定。
加速数字疗法实施并提供教程以培养可操作技能的策略
为了支持新的中心优先事项,核心还将参与其中。
与活跃的后期数字健康项目相关联,以包括常见的临床和实施指标
告知数字治疗的扩展方法,贡献数字治疗的培训和使用方法
研究中的使用数据和其他数字评估,以阐明行动的实施机制和
为适应性干预措施提供信息,促进对相关决定因素和策略的科学理解
实施跨诊断数字治疗,提供数字健康伦理方面的培训和资源
考虑数字疗法的获取公平性和文化相关性,并支持培训和方法
这些努力将增加数字治疗研究中代表性不足的人群的代表性。
推进 SUD 和 COD 数字疗法的科学和实践实施状态。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lisa A. Marsch其他文献
Altered states: the impact of immediate craving on the valuation of current and future opioids.
改变状态:立即渴望对当前和未来阿片类药物估值的影响。
- DOI:
10.1016/j.jhealeco.2007.01.002 - 发表时间:
2007-09-01 - 期刊:
- 影响因子:3.5
- 作者:
G. Badger;W. Bickel;L. Giordano;E. A. Jacobs;G. Loewenstein;Lisa A. Marsch - 通讯作者:
Lisa A. Marsch
Relationship Between the Sociodemographic Characteristics of Participants in the DIADA Project and the Rate of Compliance With Follow-up assessments in the Initial stage of the Intervention.
DIADA 项目参与者的社会人口特征与干预初始阶段后续评估的遵守率之间的关系。
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
María Paula Cárdenas Charry;María Paula Jassir Acosta;José Miguel Uribe Restrepo;M. Cepeda;P. Martínez Camblor;Leonardo Cubillos;Sophia M. Bartels;S. Castro;Lisa A. Marsch;Carlos Gómez - 通讯作者:
Carlos Gómez
Prescription digital therapeutics: An emerging treatment option for negative symptoms in schizophrenia
处方数字疗法:精神分裂症阴性症状的新兴治疗选择
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:10.6
- 作者:
Daniel Fulford;Lisa A. Marsch;Abhishek Pratap - 通讯作者:
Abhishek Pratap
Computer-Based Substance Use Reporting and Acceptance of HIV Testing Among Emergency Department Patients
急诊科患者基于计算机的药物使用报告和 HIV 检测接受度
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:4.4
- 作者:
I. Aronson;Charles M. Cleland;Sonali Rajan;Lisa A. Marsch;Theodore C. Bania - 通讯作者:
Theodore C. Bania
Large-scale analysis of test–retest reliabilities of self-regulation measures
自律措施的重测可靠性大规模分析
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:11.1
- 作者:
A. Z. Enkavi;Ian W. Eisenberg;Patrick G. Bissett;Gina L. Mazza;David P. MacKinnon;Lisa A. Marsch;R. Poldrack - 通讯作者:
R. Poldrack
Lisa A. Marsch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lisa A. Marsch', 18)}}的其他基金
Technology-based Treatments for Substance Use Disorders
基于技术的药物使用障碍治疗
- 批准号:
10268734 - 财政年份:2021
- 资助金额:
$ 32.74万 - 项目类别:
Technology-based Treatments for Substance Use Disorders
基于技术的药物使用障碍治疗
- 批准号:
10624444 - 财政年份:2021
- 资助金额:
$ 32.74万 - 项目类别:
Technology-based Treatments for Substance Use Disorders
基于技术的药物使用障碍治疗
- 批准号:
10469411 - 财政年份:2021
- 资助金额:
$ 32.74万 - 项目类别:
相似国自然基金
意识障碍康复的神经血管跨模态信息耦合预测-评估模型与自适应调控策略
- 批准号:62376190
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
情境意识驱动的跨平台知识交流行为及其价值共创研究
- 批准号:72374159
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
基于神经夹带的意识障碍个体化TMS调控及脑动力学机制研究
- 批准号:82371184
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
NMDAR1介导的突触易化参与rTMS在促进颅脑损伤后意识恢复中疗效个体差异的机制研究
- 批准号:82302845
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于机器学习的意识下恐惧/愉快情绪认知脑网络研究
- 批准号:32300854
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 32.74万 - 项目类别:
Barriers to early identification of dementia in a safety net healthcare system
安全网医疗保健系统中早期识别痴呆症的障碍
- 批准号:
10728164 - 财政年份:2023
- 资助金额:
$ 32.74万 - 项目类别:
Implementation of telemedicine and social network driven HIV service uptake for comprehensive HIV service integration in rural syringe service programs
实施远程医疗和社交网络驱动的艾滋病毒服务,将艾滋病毒服务全面纳入农村注射器服务计划
- 批准号:
10682889 - 财政年份:2023
- 资助金额:
$ 32.74万 - 项目类别:
DeepCertainty: Deep Learning for Contextual Diagnostic Uncertainty Measurement in Radiology Reports
DeepCertainty:放射学报告中上下文诊断不确定性测量的深度学习
- 批准号:
10593770 - 财政年份:2023
- 资助金额:
$ 32.74万 - 项目类别: